Rajeev Jain

Rajeev Jain

Director Director DIN 00092112
DIN 00092112 First appointment Jul 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2004
Shareholding value •••• Premium profile

About Rajeev Jain

Data last updated:

Rajeev Jain was a Director at Orange Pharma Private Limited (2005–2009) and Director at Nordea Lifescience Private Limited (2004–2009). The companies operate in Pharma.

DIN 00092112
Primary Designation Director
Industry Pharma
First Appointment 28 Jul 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Orange Pharma Private Limited U24239DL2004PTC124440
Director25 Jan 20052004₹7,100 (FY 2025)Active
Nordea Lifescience Private Limited U24232DL2004PTC127933
Director28 Jul 20042004₹2.38 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Orange Pharma Private Limited
Nordea Lifescience Private Limited
Premium access

Shareholding and investment profile for Rajeev Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Jain

Rajeev Jain was first appointed on 28 Jul 2004 as Director at Nordea Lifescience Private Limited. The most recent appointment on record is 25 Jan 2005 at Orange Pharma Private Limited.

Rajeev Jain held 2 earlier board appointments: Orange Pharma Private Limited (Director, 25 Jan 2005 to 28 Aug 2009); Nordea Lifescience Private Limited (Director, 28 Jul 2004 to 12 Aug 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available